IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Seeds and traits

Evogene files for IPO worth up to $60 million

1:03 PM MDT | September 24, 2013 | Rebecca Coons

Evogene (Rehovot, Israel), a plant genomics firm in which Monsanto and Bayer hold 8.7% and 4.6% stakes, respectively, announced today that it has filed a registration statement with the United States SEC for a proposed initial public offering worth up to $60 million. Additional terms have not been disclosed. According to an F-1 filing, Evogene intends to use approximately half of the proceeds to expedite the commercialization of seed traits and expand its seed traits project portfolio into new traits and crops. The remaining funds will be used to establish...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa